Technical Analysis for NVTA - Invitae Corporation

Grade Last Price % Change Price Change
F 2.46 -3.91% -0.10
NVTA closed down 3.91 percent on Thursday, January 26, 2023, on approximately normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Down

Date Alert Name Type % Chg
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Down 3 Days in a Row Weakness 0.00%
NR7 Range Contraction -3.91%
Wide Bands Range Expansion -3.91%
Wide Bands Range Expansion -6.46%
Upper Bollinger Band Touch Strength -6.46%
Gapped Down Weakness -6.46%
Wide Bands Range Expansion -9.89%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
50 DMA Support about 18 hours ago
Outside Day about 18 hours ago
Down 5% about 18 hours ago
Fell Below 50 DMA about 18 hours ago
Fell Below Previous Day's Low about 18 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Invitae Corporation Description

Invitae Corporation processes DNA-containing samples, analyzes information about patient-specific genetic variation, and generates test reports for physicians and their patients using an integrated portfolio of laboratory processes, software tools, and informatics capabilities. The company's product is an assay of 216 genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, and other hereditary conditions comprising 85 various genetic disorders and 17 targeted panels. It also solutions that enable sharing of genetic information consisting of Invitae Family History Tool, a Web or iPad application, which provides family history; and Clinvitae, a Web property that allows physicians or patients to look up individual genes and variants in order to find out additional genetic information. It operates in the United States, Israel, and internationally. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was founded in 2010 and is headquartered in San Francisco, California.


Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Cancer Biology Telehealth Telemedicine Genetics Medical Genetics Medical Test Lab Testing Neurological Disorders Molecular Diagnostics Informatics Neurology Software Tools Urological Disorders Genetic Disorder Cardiovascular Disorders

Is NVTA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 12.03
52 Week Low 1.67
Average Volume 7,062,244
200-Day Moving Average 3.07
50-Day Moving Average 2.40
20-Day Moving Average 2.26
10-Day Moving Average 2.54
Average True Range 0.24
RSI 53.92
ADX 29.5
+DI 33.70
-DI 15.02
Chandelier Exit (Long, 3 ATRs) 2.23
Chandelier Exit (Short, 3 ATRs) 2.38
Upper Bollinger Bands 2.90
Lower Bollinger Band 1.61
Percent B (%b) 0.66
BandWidth 57.10
MACD Line 0.10
MACD Signal Line 0.06
MACD Histogram 0.046
Fundamentals Value
Market Cap 434.68 Million
Num Shares 177 Million
EPS -1.87
Price-to-Earnings (P/E) Ratio -1.31
Price-to-Sales 23.28
Price-to-Book 21.28
PEG Ratio -0.51
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.96
Resistance 3 (R3) 3.00 2.87 2.88
Resistance 2 (R2) 2.87 2.74 2.85 2.85
Resistance 1 (R1) 2.67 2.66 2.60 2.63 2.82
Pivot Point 2.54 2.54 2.50 2.52 2.54
Support 1 (S1) 2.33 2.41 2.27 2.29 2.10
Support 2 (S2) 2.20 2.33 2.18 2.07
Support 3 (S3) 2.00 2.20 2.04
Support 4 (S4) 1.96